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Abstract 
Background¾Atherosclerotic lesion expansion is characterized by the 
development of a lipid rich necrotic core known to be associated with the 
occurrence of complications. Abnormal lipid handling, inflammation, and 
alteration of cell survival or proliferation contribute to necrotic core formation, but 
the molecular mechanisms involved in this process are not properly understood. 
Clec4e receptor recognizes the cord factor of M. Tuberculosis, but also senses 
molecular patterns released by necrotic cells, and drives inflammation. 
Methods¾We hypothesized that activation of Clec4e signaling by necrosis is 
causally involved in atherogenesis. We addressed the impact of Clec4e 
activation on macrophage functions in vitro, and on the development of 
atherosclerosis using low-density lipoprotein receptor deficient (Ldlr-/-) mice in 
vivo. 
Results¾ We show that Clec4e is expressed within human and mouse 
atherosclerotic lesions, and is activated by necrotic lesion extracts. Clec4e 
signaling in macrophages inhibits cholesterol efflux and induces a Syk-mediated 
endoplasmic reticulum (ER) stress response, leading to the induction of pro-
inflammatory mediators and growth factors. Chop and Ire1a deficiencies 
significantly limit Clec4e-dependent effects, whereas Atf3 deficiency aggravates 
Clec4e-mediated inflammation and alteration of cholesterol efflux. Repopulation 
of Ldlr-/- mice with Clec4e-/- bone marrow reduces lipid accumulation, ER-stress, 
macrophage inflammation and proliferation within the developing arterial lesions, 
and significantly limits atherosclerosis. 
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Conclusions¾Our results identify a non-redundant role for Clec4e in coordinating 
major biological pathways involved in atherosclerosis, and suggest that it may 
play similar roles in other chronic inflammatory diseases. 
 
Key words: necrosis; proliferation; inflammation; atherosclerosis. 
CIRCULATIONAHA/2016/022668-R1   
 5 
Clinical Perspective 
What is new? 
• Necrosis is a major feature of advanced atherosclerotic plaques. Moreover, 
increased size of necrotic lipid core is an important risk factor of plaque 
instability. Here we show that sensing of necrotic cells by the C-type lectin 
receptor CLEC4E orchestrates major pathophysiological events during 
plaque development and progression. CLEC4E signaling in macrophages 
uniquely coordinates the inflammatory response with lipid handling, foam cell 
formation, and cell proliferation, and promotes the development of advanced 
atherosclerotic lesions. 
• We also uncover a critical role for the unfolded protein response in mediating 
pro-atherogenic macrophage functions downstream of CLEC4E. 
What are the clinical implications? 
• The present work provides a mechanistic explanation for the close 
association between necrotic lipid core formation and the development of 
inflammatory advanced atherosclerotic lesions. 
• It will be important to examine if increased CLEC4E expression/signaling is 
associated with the formation of thin-cap fibroatheromatous lesions, and if 
blockade of CLEC4E signaling is able to promote plaque stabilization. 
  
CIRCULATIONAHA/2016/022668-R1   
 6 
Surprising similarities exist between the formation of advanced atherosclerotic 
lesions and tuberculous granulomas.  These are both characterized by the 
presence of a necrotic lipid core, covered, in atherosclerotic plaques by a fibrous 
cap, and in granulomas by a fibrous capsule.   
 
In atherosclerosis, increased necrotic core size and accumulation of 
inflammatory cells, alongside reduced fibrous cap thickness, are important 
determinants of acute ischemic cardiovascular events (acute myocardial 
infarction and sudden death).  Necrotic core development is initiated by the 
formation of macrophage- and smooth muscle cell-derived foam cells in 
response to the accumulation of oxidized lipoproteins in the arterial wall and the 
activation of pattern recognition innate immune receptors 1.  An acellular necrotic 
core is then established as defective efferocytosis (clearance of apoptotic cells) 
leads to secondary necrosis of foam cells and accumulation of cell debris 1. 
 
In granulomas, lipid body formation occurs in mycobacterium infected 
macrophages, and may result from both mycobacterium-derived (oxygenated 
mycolic acids) and host-derived lipids 2. The core of the granuloma accumulates 
necrotic debris from dead cells, and cholesterol crystals, which induce further 
inflammation and contribute to granuloma remodeling 3.  Formation of 
inflammatory foamy macrophages appears to be driven at least in part by the 
mycobacterium cell wall lipid trehalose-6, 6’-dimycolate (TDM) 4. Until now, the 
underlying mechanism for this has been attributed to potential recognition of 
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TDM by Toll-like receptor (TLR)2, operating in concert with the scavenger 
receptor MARCO 4, 5. However recently, the C-type lectin receptors (Clec)4e and 
4d have been identified as bona fide receptors for TDM 6, 7, thus implicating 
Clec4e and Clec4d in the events leading to granuloma formation.   
Clec4d is coupled with Clec4e, and essentially promotes Clec4e cell surface 
expression and signaling 7. Clec4e (also known as Mincle), is an ITAM-coupled 
FcRg-dependent signaling receptor, that initiates signaling by binding Syk 
through its Src homology 2 domain 8. Interestingly, Clec4e not only recognizes 
mycobacterial derived mycolate-containing lipid species (TDM, and glycerol 
monomycolate) 6, 9, but also senses host cell damage through the recognition of 
SAP130, a nuclear ribonucleoprotein released during necrotic cell death 8.  This 
places Clec4e at the center of events in granuloma formation and, by analogy, is 
highly suggestive of a role for Clec4e signaling in the molecular events at play in 
advanced atherosclerotic lesions. Therefore, we tested the hypothesis that 
Clec4e signaling promotes atherosclerosis. 
 
Methods  
Detailed methods can be found in the online-only Data Supplement. 
Animals. Experiments were approved by the Home Office, UK. Clec4e–/– 10, 
Chop–/– (Jackson laboratories), Ire1aflox/flox 11, ERAI 12 and Atf3–/– 13 mice were 
previously described. Male 6-8 week old Ldlr–/–  mice were lethally irradiated (9.5 
Gy) then injected i.v. with 1x107 bone marrow cells from donor mice. After 4 
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weeks recovery, mice were fed a high fat diet for 20 weeks. Littermate Clec4e+/+, 
Clec4e-/- mice were used as donors for bone marrow transfer.  
 
Extent and composition of atherosclerotic lesions. Quantification of lesion size 
and composition was performed as previously described 14. 
 
Cell culture.  Where indicated, cells were pre-incubated with Syk inhibitor (5µM 
,R406; Selleckchem) or Ire1a inhibitor (25µM, STF-083010; Calbiochem), and 
treated with Tunicamycin (1µg/ml, Sigma), thapsigargin (1µM, Sigma ), anti-Csf1 
(10µg/ml, R&D systems, clone 131621), rat IgG (10µg/ml, R&D system; 6-001-F), 
TDB (50µg/ml, 22:0 Trehalose; D-(+)-trehalose 6,6'-dibehenate, Avanti® polar 
lipids inc. purity >99%). BMDM proliferation was estimated by MTT assay 
(Sigma, CGD1-1KT). 
Cholesterol efflux was measured by an assay kit (MAK192, Sigma). BMDMs 
were stimulated for 24 hours with oxLDL (50µg/ml) and TDB (10µg/ml) in 
complete medium. Cells were washed and incubated with human purified HDL 
(Abserotec, 50µg/ml), mouse serum (Sigma, 5% of final volume) or medium 
(without FBS). Cholesterol efflux was calculated as follows: efflux= (MFI 
supernatant/ MFI cell lysate); % of efflux specific of the acceptor= (efflux with 
acceptor/efflux without acceptor)*100. 
 
Reporter cells. 2B4–NFAT-GFP cells expressing Clec4e and/or FcRg 8, were 
cultured in RPMI 1640 medium supplemented with 10% (vol/vol) FBS, and 
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stimulated (in RPMI 1640) with TDB (50µg/ml), PMA (500ng/ml; Sigma) or 
vehicle for 24 hours at 37°C. Apoe-/- aortic extracts were obtained from 20 week 
female Apoe-/- by cutting whole aorta in small pieces into complete medium. The 
resulting suspension was directly added to cells for 16 hours. 
 
Statistical analysis. Values are expressed as means ± s.e.m. Differences 
between values were examined using nonparametric Mann-Whitney (2 groups), 
Kruskal-Wallis followed by Dunn's test (≥ 2 groups) or two way ANOVA followed 




Clec4e senses necrosis in atherosclerotic arteries 
To determine whether Clec4e can be activated by the necrotic core of 
atherosclerotic plaques, we took advantage of a NFAT-GFP reporter T cell line 
(originally Clec4e negative) transfected with the common FcRg chain, with or 
without Clec4e. The presence of the reporter was confirmed by direct activation 
of NFAT by PMA, which induced GFP expression independently of Clec4e 
expression (Figure 1A). As expected, the synthetic Clec4e ligand (trehalose-6, 6’-
dibehenate or TDB) 6 activated NFAT, inducing GFP expression only in cells 
expressing both Clec4e and Fcg chain (Figure 1A). Importantly, activation of 
NFAT mediated GFP expression by atherosclerotic lysates from Apolipoprotein E 
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knockout (Apoe–/–) mice was also Clec4e dependent, indicating that Clec4e 
signaling can be stimulated by plaque material (Figure 1B). 
 
Clec4e is expressed in human and mouse atherosclerotic lesions 
We analyzed CLEC4E expression in human atherosclerotic lesions, and detected 
CLEC4E in myeloid cells (myeloperoxidase-positive, MPO+) infiltrating lesions, 
including intra-plaque MPO+ cells with foam cell morphology near the necrotic 
lipid core. Thus, CLEC4E is expressed in the vicinity of the necrotic core where it 
has the potential to sense necrosis (Figure 1C). In parallel, we found Clec4e 
expression on phagocytes (CD68+ cells) residing in the lipid core of advanced 
atherosclerotic lesions of Ldlr–/– mice (Figure 1D). 
 
Clec4e promotes atherosclerosis in Ldlr–/– mice 
To address the role of Clec4e during atherogenesis in vivo, we performed a bone 
marrow (BM) transplantation experiment in Ldlr–/– mice. Lethally-irradiated Ldlr–/– 
mice were reconstituted with either Clec4e+/+ (Clec4e+/+ BM ® Ldlr–/–) or Clec4e–
/– (Clec4e–/– BM ® Ldlr–/–) BM, and fed a high fat diet (HFD) for 20 weeks to 
induce advanced atherosclerotic lesions. Atherosclerosis was analyzed by Oil 
red O staining on the aortic sinus and the aortic arch. Clec4e deficiency in BM-
derived cells led to a significant reduction in lesion development (30% to 35%) at 
both sites (Figures 1E and 1F), despite no change in the levels of plasma total 
cholesterol, HDL-cholesterol, triglycerides, and no change in animal weight 
(Figure I in the online-only Data Supplement). Closer inspection of Oil red O 
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staining revealed increased accumulation of neutral lipids in plaques of Clec4e+/+ 
BM ® Ldlr–/– mice as compared to Clec4e–/– BM ® Ldlr–/– mice, suggesting a role 
for Clec4e in foam cell formation (Figure 1G). 
 
Clec4e signaling enhances neutral lipid accumulation in macrophages 
To understand how Clec4e might promote intracellular lipid accumulation, we 
determined whether Clec4e enhanced phagocytosis of oxLDL. Bone marrow-
derived macrophages (BMDMs) from Clec4e+/+ and Clec4e–/– mice were 
stimulated overnight with and without the synthetic Clec4e ligand, TDB, prior to 
incubation with Dil-oxLDL for 4 hours and analysis by flow cytometry. Clec4e+/+ 
and Clec4e–/– BMDMs phagocytosed similar amounts of Dil-oxLDL, and pre-
stimulation of Clec4e neither enhanced phagocytosis of Dil-oxLDL nor altered 
CD36 expression (Figure 2A). However, when we stained BMDMs and peritoneal 
macrophages (PEMs) incubated for 24 hours with unconjugated oxLDL using 
Bodipy 493/503 (a specific fluorescent dye for neutral lipids), we found WT cells 
accumulated more neutral lipids compared to Clec4e–/– cells (Figure 2B and 2C). 
Furthermore, stimulation of Clec4e with TDB strongly enhanced lipid droplet 
accumulation in WT but not Clec4e–/– macrophages (Figure 2B and 2C).  
 
We speculated that the Clec4e induced accumulation of lipids could be due to a 
reduction in macrophage cholesterol efflux, because gene expression analysis 
revealed that TDB stimulation reduced the expression of both Abca1 and Abcg1 
in WT but not Clec4e–/– macrophages (Figure 2D). To test this hypothesis, we 
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loaded BMDMs of Clec4e+/+ and Clec4e–/– mice with oxLDL for 24 hours in the 
presence or absence of TDB, and performed cholesterol efflux analysis using 
either mouse serum or the ApoA1-rich cholesterol acceptor, HDL. Compared to 
foam cells incubated with no acceptor, both mouse serum and human HDL 
increased the amount of fluorescent cholesterol released by 20% to 15%, 
respectively (Figure 2E). TDB significantly inhibited cholesterol release, and this 
was Clec4e dependent as no inhibition by TDB was observed in Clec4e–/– 
macrophages (Figure 2E).  
 
We investigated the role of Clec4e in cholesterol efflux further by flow cytometric 
analysis of Abca1 expression, and found that TDB decreased oxLDL induced 
Abca1 expression in PEMs (Figure 2F). To mimic the microenvironment of 
atherosclerotic plaques, we incubated macrophages with necrotic extracts of 
atherosclerotic Apoe–/– aortas, containing both lipids and necrotic stimuli. We 
found that Clec4e expression in PEMs significantly prevented the up-regulation 
of Abca1 in response to stimulation with plaque extracts (Figure 2G), indicating 
that Clec4e deficiency favors Abca1 expression in a lipid-rich environment. Our 
data point to a new role for Clec4e in the development of macrophage-derived 
foam cells via inhibition of cholesterol efflux. 
 
Clec4e induces an unfolded protein response (UPR) in macrophages  
Homeostasis of the endoplasmic reticulum (ER) is a tightly regulated process. 
Activation of the UPR upon ER stress aims to restore cellular homeostasis by 
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attenuating overall protein translation, degrading aberrant ER proteins and 
promoting expression of specific sets of genes to resolve the stress. However, if 
unresolved, ER-stress leads to cell death. During atherosclerosis, ER-stress in 
lesional macrophages 15, 16 promotes the development of large necrotic cores via 
overactivation of the transcription factor CHOP and excessive induction of 
apoptosis. Since Clec4e signaling induces NFAT activation, which requires 
calcium efflux from ER stores, and leads to accumulation of neutral lipids in 
macrophages, we hypothesized that UPR-associated proteins may mediate, at 
least in part, Clec4e dependent effects in macrophages.  
 
The lesions of Clec4e+/+ BM ® Ldlr–/– mice showed increased accumulation of 
MOMA-2+ foam cells (even when quantified per plaque surface area) compared 
to lesions of Clec4e–/– BM ® Ldlr–/– mice (Figure 3A and 3B). Furthermore, we 
found a substantial reduction of both Syk phosphorylation (Figure 3A and 3B) 
and Chop expression (Figure 3C and 3D) in foam cells of Clec4e–/– BM ® Ldlr–/– 
mice compared to mice transplanted with Clec4e+/+ BM. Interestingly, the number 
of apoptotic cells (Hoechst+TUNEL+) per section was similar between the two 
groups (data not shown). Therefore, we examined whether Clec4e signaling 
could directly activate the UPR in macrophages in vitro. We studied the induction 
of different markers specific to UPR/ER-stress at both the level of mRNA and 
protein. Whereas the basal level of expression of Clec4e was high in PEMs 
(Figure IIA in the online-only Data Supplement), the low basal level of Clec4e on 
BMDMs could be boosted by TDB stimulation in a Clec4e/Syk dependent 
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manner (Figure 3E, 3F and 3G). Stimulation of Clec4e/Syk by TDB induced Chop 
expression and Xbp1 mRNA splicing (sXbp1) (Figure 3E and 3F), suggesting the 
activation of several branches of the UPR. In turn, ER-stress induction by either 
thapsigargin or tunicamycin, promoted Clec4e expression in macrophages 
(Figure IIB in the online-only Data Supplement). Furthermore, Clec4e stimulation 
by TDB, like ER-stress induction by thapsigargin, induced an over-expression of 
Ire1a protein and nuclear translocation of Chop in both BMDMs and PEMs 
(Figure 3H and 3I, and Figure IIC and IID in the online-only Data Supplement). 
We confirmed activation of Ire1a RNA splicing activity (known to be responsible 
for Xbp1 splicing) after Clec4e stimulation using PEMs derived from the 
transgenic ER-stress-activated indicator (ERAI) mice (Figure 3J), which express 
the fluorescent Venus protein upon Ire1a activation 12. 
 
Clec4e signaling promotes a pro-inflammatory phenotype in macrophages 
through activation of the UPR 
sXbp1 and Chop are integrated into innate and adaptive immune pathways, and 
affect cell fate and differentiation 17. We found that lesions of Clec4e+/+ BM ® 
Ldlr–/– mice had enhanced activation of innate and adaptive immune cells 
compared to lesions of Clec4e–/– BM ® Ldlr–/– mice. This was apparent through 
the significant increase in macrophages (Figure 3A) and T cells (Figure IIIA in the 
online-only Data Supplement) and the enhanced expression of inflammatory 
cytokines, e.g., Il1b, by plaque foam cells of Clec4e+/+ BM ® Ldlr–/– mice (Figure 
4A). We also detected an increase in both CD8+ and CD4+ memory T cells 
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(CD44high) in the spleen of Clec4e+/+ BM ® Ldlr–/– compared to Clec4e–/– BM ® 
Ldlr–/– mice (Figure IIIB in the online-only Data Supplement), despite a similar 
distribution of immune cells between the 2 groups (Figure IIIC in the online-only 
Data Supplement). To examine the role of the ER stress in mediating 
inflammatory responses downstream of Clec4e, we studied BMDMs and PEMs 
derived from WT, Chop–/– and Ire1a–/– mice. Stimulation of Clec4e/Syk signaling 
by TDB induced the expression of several pro-inflammatory mediators (including 
Tnf-a and Ccl2) in BMDMs but reduced the expression of the anti-inflammatory 
cytokine TGFb (Figure IV in the online-only Data Supplement). This pro-
inflammatory macrophage phenotype was reproduced in WT PEMs (Figure 4B), 
but was drastically prevented in Chop–/– macrophages (Figure 4B). Intriguingly, 
Clec4e expression was partially controlled by Chop (Figure 4C), which may have 
contributed to the marked resistance of Chop–/– macrophages to Clec4e 
stimulation. Chop deficiency also substantially reduced sXbp1 expression in 
response to TDB and thapsigargin (Figure 4D), suggesting that Chop was 
activated upstream of Ire1a. Analysis of Ire1a–/– PEMs by flow cytometry showed 
no difference in Clec4e expression compared to WT PEMs (Figure 4E), 
indicating that the control of Clec4e expression by Chop occurs upstream of 
Ire1a activation. Interestingly, Ire1a–/– PEMs still showed a drastic reduction in 
Clec4e-dependent production of pro-inflammatory cytokines compared to WT 
PEMs (Figure 4F), despite no change in Clec4e expression. Furthermore, 
pharmacological inhibition of Ire1a splicing activity (STF inhibitor) in WT BMDMs 
recapitulated the Ire1a deficient phenotype (Figure VA and VB in the online-only 
CIRCULATIONAHA/2016/022668-R1   
 16 
Data Supplement). These results reveal a crucial role for Chop and Ire1a 
activation in the induction of a pro-inflammatory macrophage phenotype 
downstream of Clec4e, which may positively feed back to sustain Clec4e 
signaling through upregulation of Clec4e expression. 
 
Clec4e/Chop/Ire1a signaling promotes macrophage proliferation 
When analyzing pro-inflammatory cytokine profile we found that the macrophage 
survival factor, Csf-1 was induced by TDB, and its expression was dependent on 
Ire1a function (Figure VC in the online-only Data Supplement). This suggested a 
potential role for Clec4e signaling in macrophage survival or proliferation. We 
investigated this further by analyzing the expression of Ki67 in plaque 
macrophages. We found a significant reduction in the number of MOMA-2+ Ki67+ 
foam cells in Clec4e–/– BM ® Ldlr–/– compared to Clec4e+/+ BM ® Ldlr–/– mice 
(Figure 5A). Furthermore, stimulation of macrophages with TDB in vitro promoted 
Ki67 expression, whereas thapsigargin-induced ER-stress promoted apoptosis 
(Figure 5B). TDB stimulation also reduced intra-nuclear levels of the cell cycle 
inhibitor p21(WAF1/Cip1) (Figure 5C), along with a down-regulation of Maf-b and c-
Maf but up-regulation of Myc and Klf4 gene expression (Figure 5D), a phenotype 
previously shown to be crucial for macrophage self-renewal 18. TDB stimulated 
both macrophage proliferation and Csf1 expression in a Clec4e dependent 
manner (Figure 5E and 5F), and proliferation was significantly reduced by 
blockade of Csf1 production (Figure 5G). Finally, TDB-induced Csf1 expression 
(Figure 5H, and Figure V in the online-only Data Supplement) and proliferation 
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(Figure 5I) were markedly attenuated in the absence of Chop, or after inhibition 
of Ire1a activity. Together, this data suggests Clec4e stimulation promotes 
macrophage proliferation, at least in part through induction of UPR/ER-stress-
associated proteins. 
 
Activating transcription factor 3 (Atf3) regulates Clec4e signaling in 
macrophages 
Atf3, a member of the CREB family of basic leucine zipper transcription factors, 
is part of the UPR and has been shown to regulate both inflammatory and 
metabolic pathways 19, 20. Atf3 has an inhibitory role in atherosclerosis 21; limiting 
macrophage foam cell formation by regulating intracellular neutral lipid 
accumulation through inhibition of cholesterol 25-hydroxylase 21, and modulating 
cytokine production and ER stress 21-23. We hypothesized that if Atf3 is induced 
in response to Clec4e stimulation, it may limit macrophage foam cell formation 
and inflammation. Stimulation of macrophages with TDB induced nuclear 
translocation of Atf3 in a Clec4e dependent manner, in both PEMs and BMDMs 
(Figure 6A and 6B). Interestingly, Atf3 negatively regulated the acquisition of a 
pro-inflammatory phenotype by macrophages as shown by the significant 
increase of Clec4e, Tnf and Ccl-2 expression in Atf3-/- BMDMs incubated with 
TDB, compared to WT BMDMs (Figure 6C). Atf3 deficiency also promoted 
increased Csf1 expression (Figure 6D) and enhanced proliferation (Figure 6E) in 
response to TDB, compared with WT macrophages. We found that oxLDL-
induced Abca1 expression was reduced in Atf3-/- BMDMs, but Atf3 deficiency did 
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not alter TDB-dependent modulation of Abca1 (Figure 6F). Thus implicating a 
negative feedback loop in which Atf3 induced downstream of Clec4e limits 
Clec4e-dependent macrophage inflammation and proliferation, but not foam cell 
formation. Enhancement of the necrosis-Clec4e signaling axis could in part 
explain the acceleration of atherosclerosis in Atf3-/- mice 21. 
 
Discussion 
Previous studies reported activation of macrophage inflammatory responses 
downstream of Clec4e/FcRg/Syk/Card9/Nf-kB signaling 24. Here, we show that 
Clec4e stimulation induces a Syk-dependent ER stress-like response that directly 
contributes to Clec4e-dependent inflammatory responses. Chop and Ire1a 
promote whereas Atf3 limits and fine-tunes Clec4e-dependent atherogenic 
events. 
The contribution of Chop to Clec4e-induced events is, at least in part, due to the 
upregulation of Clec4e expression. Chop binds and heterodimerizes with other 
members of the C/EBP family, most notably C/EBPb, and in doing so may inhibit 
or promote of C/EBPb transcriptional activity. Interaction between Chop and 
C/EBPb is required for nuclear localization of Chop and stabilization of C/EBPb 
25. In this regard, it is interesting to note that Clec4e was initially identified by 
virtue of its upregulation by LPS, which is mediated by C/EBPb 26. C/EBPb has 
since been proposed to coordinate Clec4e expression and its downstream 
inflammatory gene induction 27. Therefore we speculate that Chop-dependent 
induction of Clec4e involves functional interaction between Chop and C/EBPb. 
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On the other hand, Ire1a deletion substantially inhibited Clec4e-induced 
inflammation without altering Clec4e expression. This is consistent with the role 
of Ire1a in promoting inflammatory responses via recruitment of Traf2 and 
activation of Nf-kB 28 and Jnk 29 pathways, and/or via the production of sXbp1 17, 
30. 
Macrophage proliferation may contribute to atherosclerosis 31. However, the 
mechanisms that orchestrate macrophage proliferation remain poorly defined. 
Here, Clec4e induced macrophage proliferation in a Chop- and Ire1a-mediated 
Csf1 dependent manner, which is consistent with the major impact of Csfr1 
deletion on macrophage accumulation in atherosclerotic lesions 32. Clec4e also 
induced a permissive state for macrophage proliferation through coordinated 
expresion of transcription factors that are critical for self-renewal of differentiated 
macrophages; MafB, c-Maf, Klf4 and c-Myc 18. Additional studies are needed to 
define the pathways linking Clec4e to these transcription factors. However, it is 
known that C/EBPb isoform LIP plays a determinant role in repressing MafB 33, 
suggesting a similar role for Chop downstream of Clec4e signaling. 
 
The role of Chop in atherosclerosis has mostly focused on induction of apoptotic 
cell death 23. Therefore, it is intriguing that Chop induction downstream of Clec4e 
did not promote apoptosis. The level of Chop induction by Clec4e is less 
pronounced compared to other inducers of ER stress, and therefore may not be 
sufficient to promote cell death. Furthermore, any pro-apoptotic effects of Chop 
may have been mitigated by the marked induction of Csf1 downstream of 
CIRCULATIONAHA/2016/022668-R1   
 20 
Clec4e, and the concomitant upregulation of sXbp1, another macrophage 
survival factor 34. A recent study reported a proliferative role for Chop in vascular 
smooth muscle cells (VSMCs), through downregulation of Klf4 35. Klf4 may either 
repress or enhance cell proliferation, dependent on cell sensitivity to p21Waf/Cip1 36, 
37. Reduced p21Waf/Cip1, as observed in our Clec4e-stimulated macrophages, 
would favor a proliferative role of Klf4.  
In agreement with previous reports linking ER stress to increased macrophage 
foam cell formation 38, 39, stimulation of Clec4e resulted in an ER stress-like 
response and concomitant induction of lipid body formation. The previous studies 
attributed the induction of foam cell formation to ER stress-induced upregulation 
of CD36 and/or Msr1, or to the promotion of an M2 macrophage phenotype 38, 39. 
Instead, our findings point to a role for Clec4e in the regulation of cholesterol 
efflux, in part through the inhibition of Abca1 expression. It is noteworthy that 
Chop represses Pparg 40 and so might limit downstream Abca1 transcription and 
Abca1-mediated cholesterol efflux 41. Also of relevance here, Xbp1 activation 
triggers a triglyceride biosynthetic program in dendritic cells, which leads to lipid 
body formation 42.  
Additional work is needed to understand how Clec4e is engaged within 
atherosclerotic lesions. Clec4e signaling may be induced directly through 
recognition of necrotic cell death 8, with or without concomitant (trans)activation 
of other pattern recognition receptors. Direct activation by other (yet unknown) 
ligands is also possible. In this regard, it is interesting to note that human, but not 
murine, CLEC4E binds cholesterol crystals, and mediates cholesterol-induced 
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pro-inflammatory responses in macrophages 43. This provides further support to 
the high relevance of our results to human atherogenesis. 
The present study identified important roles for Clec4e in several aspects of 
macrophage function. However, additional studies will be needed to tease out the 
interactions between those biological pathways, particularly foam cell formation, 
proliferation and inflammatory status. 
Finally, the study focused on the role of Clec4e in macrophages. Clec4e is not 
expressed on lymphocytes. However, other myeloid cells may contribute to 
Clec4e-dependent effects during atherosclerosis. 
In conclusion, Clec4e plays a critical non-redundant role in promoting a pro-
atherogenic macrophage phenotype, and aggravates atherosclerotic lesion 
inflammation. Our results support an important role for necrotic cell signaling in 
promoting the progression of advanced atherosclerotic plaques, and potential 
pathways for therapeutic intervention.
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Figure legends 
Figure 1. Clec4e senses necrotic debris and promotes atherosclerosis. 
A,B- Flow cytometry analysis of GFP expression by 2B4–NFAT-GFP cells 
transfected with Clec4e and/or FcRg expression plasmids, then treated for 24 
hours with PMA, TDB or vehicle alone (A), or with aortic extract from Apoe-/- 
mice (B). Data were obtained using technical quadruplicates, and are 
representative of at least 2 independent experiments. (*p<0.05, **p<0.01: 
FcRg vs FcRg + Clec4e in the same condition, Kruskal-Wallis & Dunn post 
test). C- Expression of CLEC4E protein by myeloid cells in human 
atherosclerotic coronary artery. Top left panel: overview of an atherosclerotic 
plaque using Masson's trichrome. Top right panel: distribution of myeloid cells 
(MPO+) within the atherosclerotic lesion analyzed by fluorescence microscopy 
(Top panel's scale bars: 300µm). Bottom panels: CLEC4E expression by 
media infiltrating myeloid cells (left panel) and foam cells near the 
necrotic/lipid core of the plaque (right panel) analyzed by confocal microscopy 
(Bottom panel's scale bars: 20µm). D- Confocal analysis of Clec4e expression 
by phagocytes (CD68+) in atherosclerotic lesions of Ldlr-/- after BM transfer 
and 20 weeks of HFD. Images are representative of 3 mice (Scale bar: 
50µm). E, F- Analysis of atherosclerosis development in Ldlr-/- mice engrafted 
with Clec4e+/+ or Clec4e-/- BM and kept under HFD for 20 weeks (n=8 
mice/group). Representative Oil red O' stainings of aortic root cross sections 
(E) and of "en face" aortic arch (F) with histograms depicting atherosclerosis 
lesion density (% of vessel area) (Scale bar: 500µm). G- Representative 
images of Oil red O stainings in plaques of Clec4e+/+ BM -> Ldlr-/- and Clec4e-/- 
BM -> Ldlr-/- (Scale bar: 100µm) with histograms depicting Oil red O density 
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(% of plaque area). *p<0.05, **p<0.01, 2-way ANOVA (E) and Mann-Whitney 
test (F, G). 
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Figure 2. Clec4e enhances neutral lipid accumulation in macrophages, 
through inhibition of cholesterol efflux. A- Flow cytometry analysis of Dil-
oxLDL uptake (4 hours) by BMDMs from Clec4e+/+ and Clec4-/-, with or 
without pre-conditioning with TDB, and CD36 expression by BMDMs in the 
same conditions. B, C- Flow cytometry analysis of Bodipy 493/503 staining on 
BMDMs (B) and PEMs (C) from Clec4e+/+ and Clec4-/- incubated in the 
presence, or not, of oxLDL, with or without TDB for 24 hours. *p<0.05 
Clec4e+/+ vs Clec4e-/- oxLDL + TDB-treated cells. D- RT/Q-PCR analysis of 
Abca1 and Abcg1 mRNA expression by Clec4e+/+ and Clec4e-/- BMDMs 
treated with or without TDB. *p<0.05, TDB- vs vehicle-treated BMDMs. E- 
Cholesterol efflux analysis of Clec4e+/+ and Clec4e-/- BMDMs stimulated for 24 
hours with oxLDL ± TDB, using fluorescently labelled cholesterol. The efflux of 
cholesterol was induced by the addition of mouse serum or human purified 
HDLs in the medium for 4h. *p<0.05 TDB- vs vehicle-treated BMDMs + 
oxLDL. F- Flow cytometry analysis of Abca1 expression on PEMs stimulated 
with oxLDL (black line), oxLDL with TDB (bleu line). Grey line represents 
unstained cells. G- Flow cytometry analysis of Abca1 expression by PEMs 
from Clec4e+/+ and Clec4e-/- mice stimulated necrotic aortic extract from Apoe-
/- mice for 24 hours. *p<0.05 Apoe-/- necrotic aorta vs vehicle-treated Clec4e+/+ 
PEMs; *p<0.05 Apoe-/- necrotic aorta vs vehicle-treated Clec4e-/- PEMs; # 
p<0.05 Clec4e-/- vs Clec4e+/+ vehicle-treated PEMs. Data were obtained using 
technical quadruplicates, and are representative of at least 2 independent 
experiments. Kruskal-Wallis with Dunn's test (B-E, G). 
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Figure 3. Stimulation of the Clec4e/Syk axis induces UPR in 
macrophages. A, B- Epifluorescence analysis of the expression of the foam 
cell-associated epitope MOMA-2 and phospho-Syk Y323 (pSyk) on aortic root 
cross-sections (n= 8 mice/group). Representative images of MOMA-2 and 
pSyk stainings in lesions of Clec4e+/+ BM -> Ldlr-/- and Clec4e-/- BM -> Ldlr-/- 
mice (A) and quantification of MOMA-2+ area and co-stained MOMA-2/pSyk 
area (B) (Scale bar: 250µm). C, D- Epifluorescence analysis of the expression 
of Chop by MOMA-2+ cells on aortic root cross sections of Clec4e+/+ BM -> 
Ldlr-/- and Clec4e-/- BM -> Ldlr-/- mice (n= 8 mice/group). Quantification of 
Chop MFI in MOMA-2+ area (C) and representative images of MOMA-2 and 
Chop stainings in lesions (D) (Scale bar: 150µm). E, F- RT/Q-PCR analysis of 
Clec4e, sXbp1 and Chop expression by Clec4e+/+ and Clec4e-/- BMDMs (E) or 
BMDMs with or without Syk inhibitor (Syk inh; R406) (F) stimulated with TDB 
for 12 hours. *p<0.05 TDB- vs vehicle-treated Clec4e+/+ BMDMs vs all other 
conditions. G, H, I- Clec4e, Ire1a and Chop protein expression by BMDMs 
treated with TDB or thapsigargin for 16 hours analyzed by confocal 
microscopy (Scale bar: 50µm). (n= 30-50 cells/conditions; *p<0.05, 
***p<0.001 TDB- or thapsigargin- vs vehicle-treated BMDMs; Scale bar: 
20µm). J- Flow cytometry analysis of Venus-FP expression by WT or ERAI 
PEMs incubated in the presence the vehicle alone, or TDB for 24 hours. Data 
were obtained using technical quadruplicates, and are representative of 4 
independent experiments. Mann-Whitney (B, C) and Kruskal-Wallis with 
Dunn's test (E, F, H, I). 
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Figure 4. Clec4e-induced UPR activation stimulates pro-inflammatory 
cytokine production by macrophages, via Chop and Ire1a. A- 
Epifluorescence analysis of the expression of Il-1b by MOMA-2+ cells on cross 
section of Clec4e+/+ BM -> Ldlr-/- and Clec4e-/- BM -> Ldlr-/- mice. 
Representative images of MOMA-2 and Il-1b stainings in lesions and 
quantification of Il-1b MFI in MOMA-2+ area (Scale bar: 150µm). B- Pro-
inflammatory cytokine (Tnf-a, Il-6 and Il-1b) secretion by Clec4e+/+, Clec4e-/- 
and Chop-/- PEMs stimulated with TDB for 16 hours. *p<0.05 TDB-stimulated 
Clec4e+/+ BMDMs vs all conditions. C- Flow cytometry analysis of Clec4e 
expression on PEMs from Clec4e+/+, Clec4e-/- and Chop-/- mice. Dotted line on 
the histogram represents Clec4e staining on Clec4e-/- PEMs. *p<0.05 
Clec4e+/+ vs Chop-/- PEMs. D- RT/Q-PCR analysis of Clec4e and sXbp1 by 
Chop+/+ and Chop-/- BMDMs treated with TDB or thapsigargin for 12 hours. 
*p<0.05, Chop+/+ vs Chop-/- BMDMs from the same condition. E- Flow 
cytometry analysis of Clec4e expression on PEMs from Ire1a+/+ (LysM-Cre- 
Ire1aflox/flox) and Ire1a-/- (LysM-Cre+ Ire1aflox/flox) mice. F- Cytokine (Tnf-a, Il-6, 
Il-1b, Il-1a, Ccl-2 and Il-10) secretion by Ire1a+/+ and Ire1a-/- PEMs 
stimulated with TDB for 16 hours. *p<0.05 TDB- vs Vehicle stimulated Ire1a+/+ 
BMDMs. Data were obtained using technical quadruplicates, and are 
representative of at least 2 independent experiments. Mann-Whitney (A, C) 
and Kruskal-Wallis with Dunn's test (B, D, F). 
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Figure 5. Clec4e induces proliferation of macrophages via a Csf1-
autocrine loop regulated by Chop and Ire1a. A- Epifluorescence analysis 
of the expression of Ki67 by MOMA-2+ area on aortic cross sections of 
Clec4e+/+ BM -> Ldlr-/- and Clec4e-/- BM -> Ldlr-/- mice (n= 8 mice/group). 
Representative images of MOMA-2 and Ki67 stainings in lesions and 
quantification of MOMA-2+Ki67+ cells per sections (Scale bar: 25µm). *p<0.05, 
Mann-Whitney test. B- Ki67 protein expression by BMDMs treated with 
vehicle, TDB or thapsigargin (12 hours) and TUNEL stainings analyzed by 
confocal microscopy (Scale bar: 50µm). C- p21(Waf1/Cip1) protein expression by 
BMDMs treated with, or without, TDB for 12 hours and analyzed by confocal 
microscopy (Scale bar: 20µm). *p<0.05, Student t test (n=30-50 cells/group). 
D- RT/Q-PCR analysis of Klf4, Myc, cMaf and Maf-b mRNA expression by 
BMDMs treated with or without TDB for 12 hours. *p<0.05, TDB- vs vehicle-
treated BMDMs, Mann-Whitney test. E- Cell number estimation experiment 
using MTT assay. The percentage of proliferation is expressed as = (MTT 
O.D. sample * 100 / MTT O.D. vehicle)-100. Clec4e+/+ and Clec4e-/- BMDMs 
were stimulated for 24 hours with TDB. *p<0.05, TDB- vs vehicle-treated 
BMDMs. F- ELISA titration of Csf1 secretion by PEMs from Clec4e+/+ and 
Clec4e-/- mice stimulated with TDB for 24 hours. *p<0.05, Clec4e+/+ vs Clec4e-
/- TDB-treated PEMs. G- TDB induced BMDMs proliferation can be abrogated 
by the addition of an anti-Csf1 antibody in the culture medium **p<0.01, 
Isotype vs anti-Csf1 treated BMDMs, 2-way ANOVA test. H- RT/Q-PCR 
analysis of Csf1 mRNA expression by BMDMs (Clec4e+/+, Chop-/- or Clec4e-/-) 
treated with or without TDB for 16 hours. *p<0.05, TDB- vs vehicle-treated 
BMDMs from the same genotype. I- TDB induced BMDMs proliferation 
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requires Chop and Ire1a expression. *p<0.05, TDB- vs vehicle-treated WT 
BMDMs. Data were obtained using technical quadruplicates, and are 
representative of at least 2 independent experiments. Kruskal-Wallis with 
Dunn's test (E, F, H, I). 
Figure 6. Atf3 modulates Clec4e signaling pathway in macrophages. A, 
B- Atf3 protein expression, and nuclear translocation, by BMDMs (A, Scale 
bar: 20µm) and PEMs (B, Scale bar: 10µm) treated for 16 hours with vehicle, 
TDB or thapsigargin, , analyzed by confocal microscopy. **p<0.01, ***p<0.001 
TDB- or thapsigargin- vs vehicle-treated BMDMs A, B: 20-30 cells 
analyzed/condition, data are representative of 3 independent experiments. C, 
D, E- RT/Q-PCR analysis of Clec4e, Tnf-a, Ccl-2 (C), and Csf1 (D) mRNA 
expression by Atf3+/+ and Atf3-/- BMDMs treated with or without TDB for 12 
hours. *p<0.05, Atf3-/- vs Aft3+/+ TDB-treated BMDMs. E- Percentage of 
proliferation of TDB-stimulated Atf3-/- BMDMs over TDB-stimulated Atf3+/+ 
BMDMs assessed by MTT after 36h of stimulation (*p<0.05 Atf3-/- vs Atf3+/+). 
F- RT/Q-PCR analysis of Abca1 mRNA expression by Atf3+/+ and Atf3-/- 
BMDMs treated with or without oxLDL and TDB for 12 hours. *p<0.05, oxLDL- 
and oxLDL + TDB-treated Atf3+/+ BMDMs. C-F: Data were obtained using 
technical quadruplicates, and are representative of 2 independent 
experiments. Mann-Whitney (E) and Kruskal-Wallis with Dunn's test (A, C, D, 
F). 
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SUPPLEMENTAL MATERIAL 





Animals. Animal experiments were approved by the Home Office, UK, and 
were performed under PPL 80/2426. All mice were on C57Bl/6 background. 
Clec4e–/– 1, Chop–/– (Jackson laboratories), Ire1aflox/flox 2, ERAI 3 and Atf3–/– 4 
mice were previously described. Male 6-8 week old Ldlr–/–  mice were lethally 
irradiated (9.5 Gy) then injected i.v. with 1x107 bone marrow cells from donor 
mice. After 4 weeks recovery, mice were fed a high fat diet (21 % Fat, 0.15 % 
Cholesterol, Special Diet Services) for 20 weeks. Littermate Clec4e+/+, 
Clec4e-/- mice were used as donors for bone marrow transfer to Ldlr-/- 
animals. Aorta were removed, fixed (PFA 4%, 16 hours at 4°C) and kept in 
PBS for further investigations. 
Bone marrow-derived macrophages (BMDMs) and peritoneal macrophages 
(PEMs) were derived from age- and sex-matched mice (Clec4e+/+, Clec4e-/-, 
Chop+/+, Chop-/-, LysM-Cre+ Ire1aflox/flox, LySM-Cre- Ire1aflox/flox, Atf3+/+, Atf3-/-; 
n=3-4/groups). 
 
Cholesterol analysis. Blood was obtained by cardiac puncture on EDTA. 
Plasma and cells were separated by centrifugation (15 minutes 15,000 g). 
Plasma was kept at -80°C for cholesterol analysis and cells were used to look 
at myeloid cell distribution.Triglycerides, total cholesterol and HDL were 
quantified on plasma (EDTA) by the Core Biochemical Assay lab at the 
University of Cambridge. 
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Cell culture. Cells were cultured at 37°C and in 5 % CO2 in a humidified 
incubator. Primary mouse BMDMs were prepared using femoral BM cells 
(2x106 cell/10 ml/petri dish) in BMDM medium (RPMI 1640 containing L-
glutamine + 10 % [vol/vol] heat-inactivated FBS, 100 IU/ml penicillin, 100 
µg/ml streptomycin and 30 % L929 medium). On day 4, 10 ml of fresh BMDM 
medium was added, and on day 8, adherent cells were lifted using ice-cold 
PBS, counted, pelleted, resuspended in complete medium, and used for 
stimulation at a cell density of 5x105 cell/well in 24-well plates. 
PEMs were obtained by injecting 5 ml of ice-cold PBS i.p. in mice. Peritoneal 
exudates were pelleted, resuspended in complete RPMI, and plated in 24-well 
plates at a density of 1x106 cells/well. Non-adhering cells were harvested 4 
hours after plating and the remaining PEMs were used for stimulation (>95 % 
PEMs purity, as assessed by flow CD11b+F4/80+). 
For confocal microscopy, cells (BMDM/PEMs) were seeded in Ibidi® chamber 
slides (µ-Slide 8 Well) at a density of 2x105 cell/well for 16 hours before being 
washed and stimulated. Cells were rinsed, fixed (PFA 4 % for 20 minutes at 
4°C) and kept in PBS at 4°C for further investigations. 
 
Cholesterol efflux. This was measured by an assay kit (MAK192, Sigma). 
BMDMs were stimulated for 24 hours with oxLDL (50µg/ml) and TDB 
(10µg/ml) in complete medium. Cells were then gently washed with warm 
medium (without FBS), and incubated with equilibration solution (containing 
the fluorescent cholesterol) overnight at 37°C. To induce cholesterol efflux, 
cells were washed and incubated with warm medium-containing Human 
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purified HDL (Abserotec, 50µg/ml), mouse serum (Sigma, 5% of final volume) 
or medium (without FBS). After 4 hours, supernatants were removed and cells 
were lysed with lysis buffer. Fluorescence of the supernatant and lysates were 
analyzed by VICTORX3 Plate Reader (Perkin Elmer). Cholesterol efflux was 
calculated as follows: efflux= (MFI supernatant/ MFI MFI cell lysate); % of 
efflux specific of the acceptor= (efflux with acceptor/efflux wihtout 
acceptor)*100. 
 
Flow cytometry. Cell analysis. Spleen cell suspension, obtained after 
meshing and red blood cell lysis, as well as BMDMs or PEMs were incubated 
with Fc block solution (ebiosciences, clone 93, dilution 1/200 in flow buffer 
[PBS, 1 % BSA, 2 mM EDTA, 0.01 % NaN3]) for 10 minutes at 4°C. Cells 
were then stained with fluorescently labeled anti-mouse antibodies, diluted in 
flow buffer at indicated concentration (Table I in the online-only Data 
Supplement) for 30 minutes at 4°C, prior to extensive wash and flow 
cytometry analysis. For neutral lipid staining, single cell suspensions of 
BMDMs were pelleted in PBS, resuspended with Bodipy® 493/503 (100 µM) 
diluted in PBS and incubated for one hour at 4°C. Cells were extensively 
washed in PBS and analyzed by flow cytometry. 
Cytokine titration. Cytokines were titrated in cell supernatant according to 
manufacturer instructions using Cytometric bead assay (CBA) kits from BD 
biosciences: Mouse inflammation (Il-6, Ccl-2, Il-10, Tnf-a) and FlexSet Il-1a 
and Il-1b. No Il-12p70 or Ifng were found in supernatants from BMDMs and 
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PEMs. Titration of Csf1 in culture supernatant was performed according to the 
manufacturer instructions (DuoSet R&Dsystem). 
Flow cytometer. The cytometric acquisition was performed on a LSR II 
Fortessa (BD biosciences) equipped with 4 lasers (405, 488, 561 and 640 
nm). Cell analysis was done using BD FACSDiva Software 6.0 and figure-
displayed dot plots and histograms were obtained using FlowJo software 
(TreeStar). CBA were analyzed using FCAP array v3.0. 
 
Immunofluorescence. Cryosections (conserved at -80°C) were dried for 30 
minutes, before being rehydrated in PBS for 10 minutes before the staining. 
Cryosections, as well as PFA-fixed cells, were then permeabilised in 0.1 % 
Triton X-100, 0.1 % Citrate buffer pH 6.0 (Dako) for 30 minutes. They were 
then washed in PBS, and incubated with the blocking solution (flow buffer + 5 
% serum of secondary antibody species, i.e. goat or donkey) for 30 minutes, 
before being incubated with primary antibodies diluted in the blocking solution 
at indicated concentrations (Table II in the online-only Data Supplement) 
overnight at 4°C. Samples were extensively washed with PBS and incubated 
with secondary antibodies diluted in the blocking solution at indicated 
concentrations (Table II in the online-only Data Supplement) for 4 hours. 
Samples were again washed extensively in PBS, nuclei were counterstained 
with Hoechst 33342 (Invitrogen) and samples were mounted with CC mountTM 
(Sigma). 
Apoptosis assay was performed using Roche In Situ Cell Death Detection Kit 
(Roche). 
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Sections of human coronary atherosclerotic plaque obtained by Patrick 
Bruneval, Paris, France, were collected after necropsy, were anonymized, 
and did not require specific ethics approval. The sections (paraffin-embedded) 
were rehydrated as follows: slides were heated at 50°C, dipped 3 minutes 
Xylene (2 times), 3 minutes in 50 % Xylene 50 % Ethanol 100 %, 3 minutes in 
Ethanol 100 %, 3 minutes in Ethanol 90 %, 3 minutes in Ethanol 70 % and 20 
minutes in distilled water. Sections were incubated in antigen retrieval solution 
(Citrate buffer pH 6.0; Dako) at 95°C for 1 hour. Sections were washed in 
distilled water and incubated with in 0.1 % Triton X-100, 0.1 % Citrate buffer 
pH 6.0 (Dako) for 30 minutes before being immuno-stained following the 
same protocol described above. Masson's trichrome staining of human 
sections was performed according to manufacturer's instructions (Sigma, 
HT15-1KT). 
Confocal analysis of samples was done using a Carl Zeiss LSM 700 confocal 
microscope and Zen2009 software. Epifluorescence analysis and brightfield 
imaging were done using Leica DM6000B microscope and analyzed with 
accompanying software. Images analysis was performed using Adobe 
Photoshop CS5 and ImageJ (NIH). 
 
Quantitative real time polymerase chain reaction. RNA isolated from 
macrophages was prepared using an RNeasy mini kit (Qiagen). Isolated RNA 
(≥100 ng) was reverse-transcribed using QuantiTect Rev. Transcription Kit 
(Qiagen). Real-time PCR was performed on 5 μl cDNA product (diluted 10 to 
20 times) using SYBR Green qPCR mix (Eurogentec) on a Roche Lightcycler 
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Figure I: Genetic deletion of Clec4e in bone marrow-derived cells does not change 
serum cholesterol, triglycerides, HDL-cholesterol, or weight of Ldlr-/- mice under HFD 
for 20 weeks. 
Total cholesterol, triglycerides and HDL plasma concentration (mmol/L), as well as weight (g) 
of mice from both groups of Ldlr-/- mice after 20 weeks under HFD. No significant differences 
were observed between groups. 





Figure II: ER stress induces Clec4e expression and Clec4e promotes ER-stress in 
PEMs. 
A- Representative flow charts of Clec4e expression by PEMs (CD11b+F4/80+) ex vivo. 
B- RT/Q-PCR analysis of Clec4e mRNA expression by BMDMs treated with or without 
tunicamycin (Left panel; *p<0.05, tunicamycin- vs vehicle-treated BMDMs) and of Clec4e 
mRNA expression by Chop+/+ and Chop-/- BMDMs treated with or without thapsigargin for 12 
hours (Right panel; *p<0.05, thapsigargin-treated Chop+/+ BMDMs vs all the other conditions). 
Data were obtain by using technical quadruplicates and are representative of 2 independent 
experiments. Kruskal-wallis with Dunn's post test. 
C-D Representative images of Ire1a expression (C) and Chop distribution (D) in PEMs from 
Clec4e+/+ and Clec4e-/- mice stimulated with TDB for 16 hours. Data are representative of 2 
independent experiments (Scale bars: 10µm). 
 
  




Figure III: Immunophenotypical analysis of spleen and lesions. 
A- Fluorescent immunostainings for CD3 (red) on atherosclerotic plaques from Clec4e+/+ BM -
> Ldlr-/- and Clec4e-/- BM -> Ldlr-/- mice. Autofluorescence of the tissue is depicted in green 
(Elastin & myocardium). 
B- Flow cytometry analysis of T cell distribution and activation (CD44+ expression) in the 
spleen of Clec4e+/+ BM -> Ldlr-/- and Clec4e-/- BM -> Ldlr-/- mice. 
C- Flow cytometry analysis of myeloid cell distribution (neutrophils and monocytes Ly6Chigh, int, 
low) in the spleen and blood of Clec4e+/+ BM -> Ldlr-/- and Clec4e-/- BM -> Ldlr-/- mice. 
*p<0.05, n= 8 mice/group, Mann-Whytney test (A, B). 
 





Figure IV: Clec4e/syk axis stimulates Tnf-a and Ccl-2 but inhibits Tgf-b mRNA 
expression in BMDMs. 
RT/Q-PCR analysis of Tnf-a, Ccl-2 and Tgf-b mRNA expression by Clec4e+/+ and Clec4e-/- 
BMDMs treated with or without TDB for 12 hours, in the presence or not of Syk inh. *p<0.05, 
TDB- vs untreated Clec4e+/+, Kruskal-wallis with Dunn's post test. Data were obtained using 
technical quadruplicates and are representative of 2 independent experiments. 
  




Figure V: Pharmacological inhibition of Ire1a endonuclease activity impairs Clec4e 
signaling in macrophages. 
RT/Q-PCR analysis of sXbp1, Tnf-a and Csf1 mRNA expression by Clec4e+/+ and Clec4e-/- 
BMDMs treated for 12 hours with or without TDB, in the presence or not of the Ire1a inh. 
*p<0.05, TDB- vs vehicle-treated Clec4e BMDMs, Kruskal-wallis with Dunn's post test. Data 
were obtained using technical quadruplicates and are representative of 2 independent 
experiments. 
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Panel Target Clone Fluorochrome Compagny 
MINCLE on PEMs      
  CD11b M1/70 Alexa fluor® 488 eBiosciences 
  F4/80 BM8 PE-Cy7 eBiosciences 
  Clec4E 4E9 APC Home-made 
CD36 on BMDMs      
  CD11b M1/70 Alexa fluor® 488 eBiosciences 
  CD36 No.72-1 APC Biolegend 
Spleen T cells      
  CD3 145-2C11 Alexa fluor® 488 Biolegend 
  CD4 RM4-5 Pacific Blue Biolegend 
  CD8 53-6.7 PerCP Biolegend 
  CD44 1M7 APC Biolegend 
Blood/Spleen myeloïd cells    
  CD11b M1/70 Alexa fluor® 488 eBiosciences 
  Ly6C 7/4 PE Abserotec 
 Ly6G Gr1 Pacific Blue Biolegend 
PEMs ABCA1 
 
ABCA1 5A1-1422 A647 Abserotec 
Table I: Antibodies used for flow cytometry. 






species Clone (Isotype) 
Working 
dilution Compagny (Cat n°) 
Mouse         
Clec4e  Rat 4E9 (IgG1) 1/50 MBL (D292-3) 
Atf3 Rabbit polyclonale (IgG) 1/200 Sigma (HPA001562) 
p21(Waf1, Cip1) Rabbit polyclonale (IgG) 1/200 eBiosciences (14-6715) 
Ire1a Rabbit 14C10 (IgG) 1/100 Cell signaling technology (#3294) 
Ki67 Rabbit D3B5 (IgG) 1/200 Cell signaling technology (#9129) 
pSyk (Y323) Rabbit polyclonale (IgG) 1/100 Cell signaling technology (#2715) 
MOMA-2 Rat MOMA-2 (IgG2b) 1/200 Abserotec (MCA519) 
Chop Rabbit polyclonale (IgG) 1/200 SantaCruz (sc-575) 
CD68 Goat polyclonale (IgG) 1/100 SantaCruz (sc7084) 
Il-1b Rabbit polyclonale (IgG) 1/200 Abcam (ab9722) 
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Human         
CLEC4E mouse 15H5 (IgG2b) 1/50 Invivogen (mabg-hmcl) 
MPO Rabbit polyclonale (IgG) 1/200 DAKO (A0398) 
Secondary antibodies         
Rabbit IgG (Alexa Fluor® 555) Donkey polyclonale 1/200 Thermo fisher scientific/Invitrogen (A-31572) 
Rat IgG (Alexa Fluor® 488) Goat polyclonale 1/200 Thermo fisher scientific/Invitrogen (A-11006) 
Rat IgG (TRITC) Goat polyclonale 1/200 Thermo fisher scientific/Invitrogen (A18870) 
Mouse IgG (Alexa Fluor® 647) Goat polyclonale 1/200 Thermo fisher scientific/Invitrogen (A-21235) 
Table II: Antibodies used for immunofluorescence. 
 
 




Inflammation Forward primer 5'->3' Reverse primer 5'->3' 
Ubc CACCAAGAAGGTCAAACAGGA CCCAAGAACAAGCACAAGG 
Clec4e CCCACCACACAGAGAGAGGA AGTTCTGCCCGGAAATTTGA 
Csf1 GAACAAGGCCTGTGTCCGAA CTGCTAGGGGTGGCTTTAGG 
Tnf-a GGTCCCCAAAGGGATGAG CACTTGGTGGTTTGCTACGAC 
Ccl-2 GTTAACGCCCCACTCACCT TTCTTTGGGACACCTGCTG 
Tgf-b GCAACATGTGGAACTCTACCAG CAGCCACTCAGGCGTATCA 
Proliferation     
Klf4 CCCACACTTGTGACTATGCAGG GGCGAATTTCCACCCACAGC 
Myc TTCCTTTGGGCGTTGGAAAC GCTGTACGGAGTCGTAGTCG 
cMaf GCAGGTAGACCACCTCAAGC TCGGGAGAGGAAGGGTTGTC 
Maf-b GGCAACTAACGCTGCAACTC ACGGAAGGGACTTGAACACC 
Cholesterol efflux     
Abca1 CGAGGCTCCCGGTGTTG GGCTGTACAGAAGAAGCCTCTGA 
Abcg1 TCACCCAGTTCTGCATCCTCTT GCAGATGTGTCAGGACCGAGT 
ER stress     
Xbp1 TACGGGAGAAAACTCACGGC CTTACTCCACTCCCCTTGGC 
sXbp1 AGCTTTTACGGGAGAAAACTCA GCCTGCACCTGCTGCG 
Chop CGGCCTGGGAAGCAACGCAT GTCGATCAGAGCCCGCCGTG 
Table III: Primers used for Q-PCR. 
 
